CoChat

Susceptibility Testing of Fungi to Antifungal Drugs

Open access
Sanguinetti, Maurizio, Posteraro, Brunella · 2018 · Journal of Fungi

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Abstract

Susceptibility testing of fungi against antifungal drugs commonly used for therapy is a key component of the care of patients with invasive fungal infections. Antifungal susceptibility testing (AFST) has progressed in recent decades to finally become standardized and available as both Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methods and in commercial manual/automated phenotypic methods. In clinical practice, the Sensititre YeastOne and Etest methods are widely used for AFST, particularly for sterile site isolates of Candida. Nevertheless, AFST is moving toward new phenotypic methods, such as matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), that are capable of providing rapid, and potentially more actionable, results for the treating clinician. Our objective is to summarize updated data on phenotypic methods for AFST of Candida and Aspergillus species and to assess their significance in view of opposing, but emerging, molecular genotypic methods.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/jof4030110

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Potential treatment of invasive C. glabrata infection based on mass spectrometry– antifungal susceptibility testing (MS-AFST) results. In a clinical context of prior echinocandin exposure, results of susceptibility or resistance to anidulafungin and/or fluconazole within 3 h or, in cases of isolates with FKS2 HS1 mutations, 6–12 h after testing may guide the appropriate administration of antifungal therapy [69].
Figure 1 Potential treatment of invasive C. glabrata infection based on mass spectrometry– antifungal susceptibility testing (MS-AFST) results. In a clinical context of prior echinocandin exposure, results of susceptibility or resistance to anidulafungin and/or fluconazole within 3 h or, in cases of isolates with FKS2 HS1 mutations, 6–12 h after testing may guide the appropriate administration of antifungal therapy [69].CC BY · PubMed Central
Figure 2 Potential screening of azole-resistant A. fumigatus isolates. Shown is a stepwise workflow that eliminates false-positive results (indicated by a red X) and can be helpful to build up local epidemiological data on the prevalence and phylogenetic linkage of resistant isolates. In this figure, true positives are derived from the growth of isolates on selective agar plates containing drug concentrations that range from 0.5 μg/mL for posaconazole (PSZ) to 1 to 4 μg/mL for itraconazole (ITZ) or voriconazole (VRZ). Then, isolates are identified at the species level by multilocus DNA sequencing [46] (got permission to use).
Figure 2 Potential screening of azole-resistant A. fumigatus isolates. Shown is a stepwise workflow that eliminates false-positive results (indicated by a red X) and can be helpful to build up local epidemiological data on the prevalence and phylogenetic linkage of resistant isolates. In this figure, true positives are derived from the growth of isolates on selective agar plates containing drug concentrations that range from 0.5 μg/mL for posaconazole (PSZ) to 1 to 4 μg/mL for itraconazole (ITZ) or voriconazole (VRZ). Then, isolates are identified at the species level by multilocus DNA sequencing [46] (got permission to use).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 55

Metadata

Authors
Sanguinetti, M., & Posteraro, B.
Affiliations
Università Cattolica del Sacro Cuore (IT)
Corresponding author
Sanguinetti, Maurizio
Venue
Journal of Fungi
Publisher
MDPI AG
Published
2018-09-15
Volume
4
Issue
3
Pages
110
ISSN
2309-608X (ISSN-L)
OpenAlex
W2891394773
Cited by
55
References
87
Citations by year
2026: 6 · 2025: 3 · 2024: 2 · 2023: 9 · 2022: 9 · 2021: 12 · 2020: 6 · 2019: 5 · 2018: 1
FWCI
0.88
Type
journal article
Language
en
Open access
Locations
  • Journal of Fungi (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • PubliCatt (Università Cattolica del Sacro Cuore) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Life Sciences › Immunology and Microbiology › Microbiology › Yeasts and Rust Fungi Studies
Keywords
antifungal susceptibility testing, invasive fungal infections, Candida, Aspergillus, MALDI-TOF mass spectrometry, Sensititre YeastOne, E-test, antifungal resistance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.